Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | EX-527 |
Synonyms | |
Therapy Description |
Selisistat (EX-527) inhibits SIRT1, SIRT2, and SIRT3, potentially resulting in decreased tumor cell growth (PMID: 25486469, PMID: 32711231). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
EX-527 | EX 527|Selisistat | SIRT1 Inhibitor 5 SIRT2 Inhibitor 5 SIRT3 Inhibitor 1 | Selisistat (EX-527) inhibits SIRT1, SIRT2, and SIRT3, potentially resulting in decreased tumor cell growth (PMID: 25486469, PMID: 32711231). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|